Concepedia

Kristina Lerch

KL

Statistics

Publications

4

Citations

209

H-Index

4

Active since

2012

Affiliations

Vivantes Klinikum(Current)

Charité - Universitätsmedizin Berlin

Technical University of Munich

Zimmer Biomet (Germany)

Kristina Lerch is an author at Vivantes Klinikum specializing in oncology, medicine, and hematologic oncology.

Publications per year

2012–2022

4

Publications

4

<sup>90</sup>Yttrium-Ibritumomab-Tiuxetan as First-Line Treatment for Follicular Lymphoma: 30 Months of Follow-Up Data From an International Multicenter Phase II Clinical Trial

Christian W. Scholz, Werner Linkesch, Ola Lindén et al. · Journal of Clinical Oncology · 2012 · 108 citations · Full text

Medicine, Hematology, Oncology +16

Transformation and additional malignancies are leading risk factors for an adverse course of disease in marginal zone lymphoma

A. Meyer, Andrea Stroux, Kristina Lerch et al. · Annals of Oncology · 2013 · 58 citations · Full text

Medicine, Oncology, Pathology +13

Impact of prior treatment on outcome of transformed follicular lymphoma and relapsed de novo diffuse large B cell lymphoma: a retrospective multicentre analysis

Kristina Lerch, A. Meyer, Andrea Stroux et al. · Annals of Hematology · 2015 · 25 citations

Medicine, Hematology, Oncology +10

90-yttrium-ibritumomab tiuxetan as first-line treatment for follicular lymphoma: updated efficacy and safety results at an extended median follow-up of 9.6 years

Kathrin Rieger, Rosaria De Filippi, Ola Lindén et al. · Annals of Hematology · 2022 · 18 citations · Full text

Medicine, Oncology, Pharmacotherapy +14

1–4 of 4